blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4218732

EP4218732 - TABLETS COMPRISING ELTROMBOPAG OLAMINE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  01.03.2024
Database last updated on 14.09.2024
FormerRequest for examination was made
Status updated on  19.01.2024
FormerThe application has been published
Status updated on  30.06.2023
Most recent event   Tooltip11.09.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
Novartis Pharma AG
Lichtstrasse 35
4056 Basel / CH
[2023/42]
Former [2023/31]For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
Inventor(s)01 / KAPSI, Shivakumar, G.
King Of Prussia, Pennsylvania, 19406 / US
02 / MULLER, Francis, X.
King Of Prussia, Pennsylvania, 19406 / US
 [2023/31]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2023/31]Pfister-Fu, Yixin
Novartis Pharma AG
Lichtstrasse 35
4056 Basel / CH
Application number, filing date23166852.601.08.2007
[2023/31]
Priority number, dateUS20070915761P03.05.2007         Original published format: US 915761 P
US20070947731P03.07.2007         Original published format: US 947731 P
[2023/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4218732
Date:02.08.2023
Language:EN
[2023/31]
Search report(s)(Supplementary) European search report - dispatched on:EP09.06.2023
ClassificationIPC:A61K9/14, A61K9/54, A61K47/34, A61P7/06, A61K31/4152, A61K9/20
[2023/31]
CPC:
A61K31/4152 (EP,IL,KR,US); A61K9/2077 (IL,US); A61K9/2054 (EP,IL,KR);
A61K9/00 (EA,IL); A61K47/26 (EP,IL,US); A61K47/34 (EP,IL,US);
A61K9/14 (EA,IL); A61K9/19 (EP,IL,US); A61K9/20 (IL,US);
A61K9/2018 (IL,KR); A61K9/2027 (EP); A61K9/2059 (EP,IL,KR);
A61K9/2095 (IL,US); A61P43/00 (EP,IL); A61P7/00 (EP,IL,KR);
A61P7/02 (EP,IL); A61P7/04 (EP,IL); A61P7/06 (EP,IL);
C07D231/46 (EP,IL,US); Y10T428/2982 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2024/08]
Former [2023/31]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesHR16.01.2024
TitleGerman:TABLETTEN ENTHALTEND ELTROMBOPAG OLAMIN[2023/31]
English:TABLETS COMPRISING ELTROMBOPAG OLAMINE[2023/31]
French:COMPRIMÉS COMPRENANTS DE L'ELTROMBOPAG OLAMINE[2023/31]
Examination procedure16.01.2024Amendment by applicant (claims and/or description)
16.01.2024Examination requested  [2024/08]
16.01.2024Date on which the examining division has become responsible
01.03.2024Despatch of a communication from the examining division (Time limit: M04)
11.04.2024Reply to a communication from the examining division
29.04.2024Observations by third parties
11.07.2024Observations by third parties
30.07.2024Observations by third parties
10.09.2024Despatch of a communication from the examining division (Time limit: M04)
Parent application(s)   TooltipEP07840632.9  / EP2152237
EP15199469.6  / EP3090730
Fees paidRenewal fee
07.08.2023Renewal fee patent year 03
07.08.2023Renewal fee patent year 04
07.08.2023Renewal fee patent year 05
07.08.2023Renewal fee patent year 06
07.08.2023Renewal fee patent year 07
07.08.2023Renewal fee patent year 08
07.08.2023Renewal fee patent year 09
07.08.2023Renewal fee patent year 10
07.08.2023Renewal fee patent year 11
07.08.2023Renewal fee patent year 12
07.08.2023Renewal fee patent year 13
07.08.2023Renewal fee patent year 14
07.08.2023Renewal fee patent year 15
07.08.2023Renewal fee patent year 16
27.07.2023Renewal fee patent year 17
29.07.2024Renewal fee patent year 18
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2001044474  (CURATOLO WILLIAM J [US], et al);
 [ID]US2006178518  (MOORE STEPHEN [GB]);
by applicantWO0189457
 WO03098002
 US2004019190
 WO2004096154
 US2006178518
 US7160870
 US2007105824
 WO2001US16863
 WO2003US16255
 WO2004US13468
otherUS2006178518
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.